Humana Inc. (NYSE:HUM) Stock Position Decreased by MCF Advisors LLC

MCF Advisors LLC cut its stake in shares of Humana Inc. (NYSE:HUM) by 19.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,150 shares of the insurance provider’s stock after selling 766 shares during the period. MCF Advisors LLC’s holdings in Humana were worth $801,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Benjamin F. Edwards & Company Inc. boosted its position in shares of Humana by 10.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,763 shares of the insurance provider’s stock worth $659,000 after buying an additional 172 shares during the period. AE Wealth Management LLC lifted its stake in Humana by 286.2% in the 2nd quarter. AE Wealth Management LLC now owns 3,507 shares of the insurance provider’s stock worth $1,310,000 after acquiring an additional 2,599 shares in the last quarter. Sei Investments Co. boosted its position in Humana by 17.3% during the 2nd quarter. Sei Investments Co. now owns 72,584 shares of the insurance provider’s stock worth $27,119,000 after acquiring an additional 10,687 shares during the period. Frank Rimerman Advisors LLC grew its stake in Humana by 28,250.0% during the 2nd quarter. Frank Rimerman Advisors LLC now owns 1,134 shares of the insurance provider’s stock valued at $424,000 after acquiring an additional 1,130 shares in the last quarter. Finally, Fidelis Capital Partners LLC grew its stake in Humana by 7.8% during the 2nd quarter. Fidelis Capital Partners LLC now owns 981 shares of the insurance provider’s stock valued at $339,000 after acquiring an additional 71 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.29% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Oppenheimer decreased their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Barclays boosted their target price on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Finally, Leerink Partnrs lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $302.70.

Humana Trading Up 0.7 %

Shares of Humana stock opened at $284.74 on Wednesday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $411.80. The company’s fifty day simple moving average is $273.82 and its 200-day simple moving average is $306.62. The company has a market cap of $34.29 billion, a price-to-earnings ratio of 25.22, a PEG ratio of 2.13 and a beta of 0.55. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, sell-side analysts expect that Humana Inc. will post 16.11 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.24%. Humana’s dividend payout ratio (DPR) is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.